ClinConnect ClinConnect Logo
Search / Trial NCT06874478

Respiratory Distress and Elective Cesarean Section at Term

Launched by ASSIUT UNIVERSITY · Mar 8, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how to better understand and reduce the risk of a serious condition called neonatal respiratory distress syndrome in babies born by elective cesarean section. This condition can make it hard for newborns to breathe and is a leading cause of health problems and even death in infants. The researchers want to focus on pregnant women who are planning to have a cesarean section after 37 weeks of pregnancy and who have received treatment to help their baby's lungs develop. By studying these women and their babies, the goal is to identify factors that could increase the risk of respiratory issues in newborns and find ways to improve outcomes.

To be eligible for the study, women must be between 20 and 39 years old and have a single baby due to be born at or after 37 weeks. However, women with certain health issues or complications in their pregnancy will not be included. Participants can expect to undergo some simple tests to help assess their baby’s lung health and monitor any potential risks. The findings from this trial could help doctors provide better care for mothers and their babies in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Maternal age of 20-39 years.
  • 2. Women with singleton pregnancy ≥ 37 weeks
  • 3. Pregnant women who received corticosteroid to enhance lung maturity and will be subjected to elective cesarian section (before onset of labour) within 1 week after administration of corticosteroid
  • Exclusion Criteria:
  • 1. Women with oligohydramnios or polyhydramnios.
  • 2. Women with underlying disease requiring corticosteroids.
  • 3. Pregnant women with any medical disorders such as hypertension, diabetes, renal diseases, antiphospholipid syndrome, intrauterine growth restriction, preterm premature rupture of membrane, placenta previa, antepartum haemorrhage, on anticoagulant thereby.
  • 4. Women with confirmed fetal malformation.
  • 5. Women who will refuse to participate.

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Assiut, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported